HOUSTON, TX – March 10, 2010 – Glycos Biotechnologies, Inc. (GlycosBio), an emerging biochemical company pioneering metabolic engineering and microbiology innovations to produce sustainable biochemicals, today announced it is presenting at CERAWEEK 2010 taking place March 8 – 12^th in Houston, TX.  Selected by CERA as an “Energy Innovation Pioneer”, GlycosBio is participating on a panel showcasing emerging biofuels, efficiency and E&P companies offering “disruptive technologies” for the energy future.

Recognized as the leading forum offering insight into the energy future, CERAWEEK brings together senior policy makers, energy and power executives, and financial and technology leaders from more than 55 countries.

What: “Disruptive Technologies for the Energy Future: Presentation by CERAWEEK 2010 Energy Innovation Pioneers”

Who: Daniel Monticello, Ph.D.  Vice President of Research and Development of GlycosBio

Where: CERAWEEK 2010, The Hilton Americas-Houston

When: Wednesday, March 10, 7:30 – 8:45am

For more information about CERAWEEK 2010 visit http://www2.cera.com/ceraweek2010.

About Glycos Biotechnologies, Inc.

Glycos Biotechnologies, Inc. (GlycosBio) is an emerging biochemical company pioneering the metabolic engineering of microbial strains to consume multiple non sugar-based, low value feedstocks for the production of sustainable chemicals and advanced ethanol.  By designing differentiated microorganisms, GlycosBio’s bioconversion technology lowers production cost and provides a non food energy balance savings to the chemical and biofuel industries.  GlycosBio is privately held with established global relationships focused on product commercialization.  For more information, visit www.glycosbio.com.

“Replicating what has been accomplished in our lab now in a commercial setting, and at a larger scale, is a significant achievement for GlycosBio,” said Rich Cilento, Chief Executive Officer for Glycos Biotechnologies. “Our work in the pilot plant will help the organization meet partner milestones related to the commercialization efforts we already have underway. In addition, the success of the pilot production validates the efficiency and ease-of-scale of GlycosBio’s technology in larger production systems and proves our economic models and the profit opportunities we can offer producers of chemicals and biofuels. With the pilot plant successfully operational we are now focused on engaging the marketplace to secure additional commercialization partnerships around the world.”

Unlike most emerging biotechnology companies, GlycosBio has created a platform that can uniquely consume carbon from multiple non-sugar feedstock sources to produce a variety of chemical products. This approach not only eliminates the risk of a sugar-only based feedstock strategy but also provides product flexibility and a larger addressable market opportunity for producers. In addition, GlycosBio’s technology platform has been proven to be cost competitive with the petrochemical industry, while maintaining 45-55% gross margins from plant operations.

“By using our proprietary microbes and bioprocess technologies as an alternative to conventional petrochemical-based manufacturing processes, GlycosBio has invented a sustainable and cost-efficient approach to the production of next generation bio-products,” said Paul Campbell, Ph.D., Chief Scientific Officer for Glycos Biotechnologies. “Through the creation of biologically ‘balanced’ pathways inside the microbe we have been able to uniquely develop microorganisms that naturally produce the desired end-products.”

Stewards of the environment with the vision of a future in which biotechnology discoveries and process innovations create sustainable chemical alternatives, GlycosBio’s is using only microorganisms that are non-pathogenic and have been used for years to make drugs, chemicals, and enzymes for food products and detergents. GlycosBio is focused on the production of specialty chemicals that can be used as building blocks for a wide range of applications including biodegradable and non-degradable plastics. In addition, other applications for GlycosBio’s chemicals include surfactants and fuels such as advanced ethanol. By bridging innovative metabolic engineering and efficient process design, GlycosBio discoveries will drive sustainable solutions for the world’s energy, chemicals, and materials problems.

About Glycos Biotechnologies, Inc.

Glycos Biotechnologies, Inc. (GlycosBio) is an emerging biochemical company pioneering the metabolic engineering of microbial strains to consume multiple non sugar-based, low value feedstocks for the production of sustainable chemicals and advanced ethanol. By designing differentiated microorganisms, GlycosBio’s bioconversion technology lowers production cost and provides a non food energy balance savings to the chemical and biofuel industries. GlycosBio is privately held with established global relationships focused on product commercialization. For more information, visit www.glycosbio.com.

Atingo Public Relations
Suzanne Tormollen, 281-785-1280
suzanne@atingo.com

Posted March 9, 2010, at 10:25 a.m. CST

Texas-based Glycos Biotechnologies Inc. is producing lactic acid and advanced ethanol in a pilot commercial-size facility with the capacity to produce 150,000 liters of chemicals. It’s a major benchmark in the company’s quest to commercialize its microbial technology.

The biochemical company is metabolically engineering microbial strains to consume nonsugar-based, low-value feedstocks for the production of chemicals and advanced ethanol. Those feedstocks can include multiple waste streams, such as glycerin from the oleochemicals industry or free fatty acids, according to GlycosBio CEO Rich Cilento. So many biochemical companies focus on sugar-based feedstocks that they build fierce competition and can hurt each others’ progress. “If a third of those companies are successful, it will really affect commodity prices for sugar,” he said. “Sugar is obviously a very, very important global commodity.” Not only does GylcosBio’s strategy eliminate the risks of sugar-only feedstocks, but it also provides product flexibility and a larger addressable market opportunity for producers, according to the company. In addition, the technology platform is cost competitive with the petrochemical industry, while maintaining 45 percent to 55 percent gross margins from plant operations.

Initially, GlycosBio used the common lab microbe E. coli in its process, but expanded its expertise and has been operating its pilot plant in Hempstead, Texas, since November 2009. “We have a portfolio of microorganisms, both E. coli and non-E. coli,” Cilento said. “Our strategy is to have a number of microorganisms that can create a portfolio of biochemicals.” The front end of the company’s process, which includes the microbe, feedstock and fermentation, is the same for any end product, although the microbe or feedstock will differ. But separation from the fermentation broth differs depending on the desired end products, Cilento said. The resulting specialty chemicals can be used as building blocks for a wide range of applications including biodegradable and non-degradable plastics, as well as for surfactants and fuels, according to the company.

GlycosBio’s strategy is to develop joint ventures with companies that produce waste streams compatible with its technology platform. Instead of licensing its process, GlycosBio will leverage the partners’ expertise and integrate its own technology for a shared plant. “We produce it as a partnership and sell it as a partnership,” Cilento said of the biochemical products. The company has established one partnership and another is close to finalization, but Cilento declined to release details. “We’ve been making a lot of progress, but we’ve been stealth,” he said. About four other partnerships are in early stages of discussion and Cilento hopes to have six to 10 ventures active (under construction or operating) in the next 12 to 18 months.

“People are confident in investing in our technology,” he said. “People with waste feedstocks are calling us and we’re at a point where we’re ready to help them make a product from their waste streams.”

By Seán Ottewell, Editor at Large

Significant developments in using renewable feedstocks to make fuels and chemicals are blooming. For instance, Shell International, Houston, and Cosan, Sao Paulo, Brazil, in February, signed a memorandum of understanding for a joint venture (jv) worth almost $12 billion to produce ethanol from sugar cane. The deal would create an organization with 2-billion-l./yr. ethanol capacity.

“We see joining with Cosan as a way to grow the role of low-carbon, sustainable biofuels in the global transportation fuel mix. The joint venture would also enable Shell to set up a material and profitable bio-fuels business, with the potential to deploy next generation technologies,” notes Mark Williams, downstream director.

The jv includes some of Shell’s major interests in next-generation technologies, such as its 50% stake in Iogen, Ottawa, Ont., and its 14.7% interest in Codexis, Redwood City, Calif.

Iogen has been producing cellulosic ethanol at an Ottawa demonstration plant since 2004. Production topped 581,000 liters in 2009, more than double 2008 output. For its part, Codexis focuses on developing highly efficient biocatalysts that replace costly chemical steps in low-carbon manufacturing processes.

Meanwhile, in late January DuPont Danisco Cellulosic Ethanol (DDCE), Itasca, Ill., and it jv partners, the University of Tennessee (UT), Knoxville, Tenn., and Genera Engegy, Knoxville, held a ribbon-cutting ceremony for their cellulosic ethanol demonstration facility in Vonore, Tenn., and hailed it as a world’s first. The 250,000-gal./yr. unit relies on agricultural residue such as corncobs and bioenergy crops like switchgrass as feedstocks. So far the partners have invested more than $50 million in the plant (Figure 1).

“The University of Tennessee Biofuels Initiative is the only fully integrated program that is working with farmers and agricultural industry to reliably supply the necessary feedstock so biorefineries can produce plentiful, affordable, renewable and sustainable fuels,” notes Kelly Tiller, CEO of Genera Energy and director of external operations for UT’s Office of Bioenergy Programs. Plans are in place for Tennessee farmers to devote an additional 4,000 acres to switchgrass this spring, bringing the total to 7,000 acres dedicated to that crop, she adds.

Meanwhile, Dow Chemical, Midand, Mich., which last June announced plans to work with Algenol Biofuels, Bonita Springs, Fla., to build and operate a pilot-scale algae-based integrated biorefinery at Dow’s Freeport, Texas, site, has started a major promotion of new biodiesel technologies it has to offer following the acquisition of Rohm & Haas. These include Amberlyst BD20 solid catalyst esterification technology for production of biodiesel from inexpensive low-quality feedstocks and the associated Ambersep BD19WET feedstock purification technology which extends catalyst life time.

More alcohol
This year also is proving to be a busy one for the Energy & Environmental Research Center (EERC), based at the University of North Dakota, Grand Forks, N.D.

The EERC entered into a jv program in January with Syntec Biofuel, Vancouver, B.C., to develop technology to produce butanol from biomass and waste. Syntec already has devised a catalytic thermochemical process that breaks down sustainable low-cost wood and agricultural waste into components that react to form ethanol, methanol, propanol and butanol.

“We have proven our catalyst at the lab scale and so now we need to validate these results in a pilot plant that will be built here [Vancouver],” notes Michael Jackson, Syntec CEO. “It’s fairly small, processing 1–3 t./d. of feedstock to give about 300 gal./d. of product. I’d say we have to get six months of results at 24/7 operation before going on to the next level. However, we don’t anticipate any unusual scale up problems because the process uses proven gasification and Fischer Tropsch technologies.”

Jackson also points to Syntec’s work with the University of British Columbia, Vancouver, B.C., to improve catalyst yield. “We are getting 110 gal./t. of product at the moment. About 300 gal./t. is the theoretical maximum but with the University of British Columbia’s help we think we can get to about 142 gal./t. That would be incredible.”

Glycos Biotechnologies, Houston, is focusing on metabolic engineering and has developed a number of microorganisms that can convert low-value byproducts such as crude glycerin, gums and free fatty acids into higher-value chemicals.

“GlycosBio has a demonstration facility and recently completed a pilot where they proved their proprietary microbial technology to convert glycerin into 13,000 l. of higher-value chemicals and/or advanced ethanol. This success is the precursor to full commercialization which they are working towards in Latin America,” says a spokesman.

Accenture, New York City, in a December 2009 report “Betting on Science, Disruptive Technologies in Transport Fuels” cites the company as one of 25 most likely to positively transform the supply-and-demand landscape of sustainable transport fuels and biochemicals within the next five years (see: www.accenture.com/Global/Services/By_Industry/Energy/R_and_I/Betting-on-Science.htm).

Meanwhile, the ChemPro Group, Boonton, N.J., and Mo-Fuel, Sikeston, Miss., have formed an alliance to commercialize a patented process to produce ethanol from cellulosic feedstocks. The route reportedly can handle a full spectrum of such materials, from wood chips and pulp-and-paper-plant byproducts to corn stover, rice straw, grass and even municipal waste. Moreover, its reactor design is said to enable easy addition of extra modular trains to boost capacity.

“The demonstration unit is in final assembly at our shop here in New Jersey and should be available for Mo-Fuel in the next 2–3 weeks. It’s a self-contained cellulose hydrolysis unit running a continuous process that converts cellulose into sugars which can be fermented into ethanol. It demonstrates to potential users that we have the ability to make ethanol from their cellulose materials,” said Steve Lavorerio, ChemPro’s president, in late January. “The process is also economical as an add-on to existing corn ethanol plants. It can process the low-value waste product with the potential to increase yields of ethanol by 15% and improve the value of byproducts by 50%,” he adds.

At least a dozen potential customers are lined up to trial the process, says Ted Lewis, Mo-Fuel president and chief R&D scientist. “Today it is more competitive than existing ethanol plants. But with our reduced construction and operating cost initiatives we should be able to knock the door wide open to production of biofuel that is competitive with petroleum products as well.”

Diesel and jet fuels
Also in January DOE awarded UOP, Des Plaines, Ill., a unit of Honeywell, $25 million to build a demonstration unit in Hawaii to convert cellulosic biomass. The facility will use feedstocks such as forestry, agricultural and algae residues to produce pyrolysis oil (Figure 2) that then will be upgraded to transportation fuels. The plant, which will be built at the Tesoro refinery in Kapolei, should start up in 2014.

The unit will employ rapid thermal processing (RTP) technology developed by Ensyn, Ottawa, Ont. UOP and Ensyn in 2008 formed a jv, Envergent Technologies, Des Plaines, Ill., to offer RTP (Figure 3) and further develop technology for upgrading pyrolysis oil to transportation fuels. Earlier this year an Italian power company selected RTP for a facility to convert biomass into pyrolysis oil for power generation. The plant is slated for 2012 start up.

At the same time UOP continues to develop its Ecofining technology for producing diesel fuel. The route uses hydroprocessing to convert triglycerides from natural oils and wastes into high-quality diesels — essentially isomerized paraffins in the diesel range.

“Existing technologies create a methyl ester — but this gives rise to a number of technical issues including blending and the ability of existing pipelines to handle the product,” says Graham Ellis, business manager for biorenewable energy. “The big difference between this and other renewable diesel technologies like co-processing is that we have separated the isomerization unit. So we can take any feed and produce exactly what is required in a client’s spec. We are on the Mark II version of the process now and are producing Honeywell Green Diesel at about a 20¢/gallon saving over methyl ester production. And this includes capital depreciation,” he adds.

The company also has just launched a process that takes the same feeds as Ecofining but uses selective hydrocracking to produce C10–C14 materials comparable to typical jet fuels. With help from Boeing, UOP has worked with a number of airlines including New Zealand Airways, JAL, KLM and Continental to test the product in real situations.

“We have generated 50,000–60,000 gal. from our own toll processing unit which is being used by the U.S. Navy and Air Force for testing and certification. Continental has reported slightly better fuel efficiency than with the usual jet fuel. So there is a lot of push to get swift certification of the fuel and we hope that this will happen this year. We are hoping that our process will lead to the beginning of a renewable jet fuel industry and this is a significant step,” says Ellis.

The same process also has served to convert tallow into jet fuel for the U.S. Air Force and algae into jet fuel for the Navy. “We expect to deliver 1,500 gal. to the Navy this summer; there is a huge interest worldwide in algae but there are only a small number of companies that can produce in any quantity from it. We are trying to give them a route to fuel by ensuring that the oils produced are proven to be compatible with Ecofining and renewable jet processes,” he notes.

Meanwhile, the EERC is teaming up with Whole Energy Fuels Corp., Bellingham, Wash., to develop cellulosic-based fuel additives to improve engine performance. “This technology will ultimately be used to improve engine performance using a renewable product, both in gasoline and diesel engines. In the case of diesel fuel, our additives will boost the cetane levels, improve flow properties and, most importantly, reduce particulate emissions,” explains Ed Olson, EERC senior research advisor. A new company, Mercurius Biofuels, Ferndale, Wash., has been set up to help develop and commercializee the technology.

Mixed messages on algae
The Accenture report notes that continued evolution of first-generation feedstocks such as sugar cane, corn and rapeseed for ethanol, butanol and biodiesel is limited by available biomass. Algae, says Accenture, have the potential to produce 1,200 gal./acre compared to just 48 gal./acre for soybean. However, it adds, this will take significant long-term commitment to reduce costs, which currently run in the range of $2–8/l. ($8–30/gal.).

Even so, the report points to recent algae-based tie-ups between ExxonMobil/Synthetic Genomics, Chevron/Solazyme, Valero/Solix, Shell/Cellana and BP/Martek that might well cut the 10 years it estimates for algae-derived fuels to reach commercial production.

However, researchers from the Department of Civil and Environmental Engineering at the University of Virginia, Charlottesville, Va., caution that significant environmental hurdles must be overcome before fuel production ramps up. Their work indicates that algae production consumes more energy, has higher greenhouse gas emissions and uses more water than other biofuel sources such as switchgrass, canola and corn (See: Environmental Science & Technology, http://pubs.acs.org/doi/abs/10.1021/es902838n).

As an environmentally sustainable alternative to current algae production methods, the researchers propose situating algae production ponds behind wastewater treatment facilities to capture phosphorous and nitrogen — essential nutrients for growing algae that otherwise would need to be produced from petroleum. They also are pursuing complementary research on the economic lifecycle of algae compared to other bionenergy feedstocks.

HOUSTON, TX – February 2, 2010 – Glycos Biotechnologies, Inc. (GlycosBio), an emerging biochemical company pioneering metabolic engineering and microbiology innovations that produce green chemicals, today announced the appointment of Daniel J. Monticello, Ph.D., as Vice President, Research and Development.  In this role, Dr. Monticello will be responsible for directing the lab operations for GlycosBio, including research, development and the overall efforts associated with scale-up and commercialization of GlycosBio’s proprietary microbe technology.  In addition, Dr. Monticello will be responsible for overseeing GlycosBio’s ongoing demonstration and commercialization efforts in Latin America.

“Dr. Monticello has a unique and broad set of business, management, science and technical skills not only from large, multinational biotechnology organizations but also from the start-up environment,” said Paul Campbell, Ph.D., Chief Science Officer for Glycos Biotechnologies.  “His in-depth experience in metabolic engineering as well as industrial fermentations will directly impact and contribute to the ongoing development of GlycosBio’s bioconversion technologies.  Dr. Moniticello is a vital addition to our team and will help GlycosBio meet our long-term scientific and business goals.”

Dr. Monticello joins GlycosBio with more than 20 years of experience in industrial biotechnology.  Prior to joining GlycosBio, Dr. Monticello was Co-Founder of Molecular LogiX, Inc., an early stage biotechnology company.  While at Molecular LogiX, Dr. Monticello was responsible for overseeing the day-to-day operations including finance, strategic planning, science and technology development.  Before founding Molecular LogiX, Dr. Monticello was Vice President, Research and Development and Co-Founder for Energy Biosystems Corporation (ENBC).  In addition to his entrepreneurial experience, Dr. Monticello held several project and research management positions for Miles, Inc., in both the Biotechnology and Enzyme Products Divisions.  Dr. Monticello has contributed to more than 20 issued US patents, is an active presenter in the scientific community and has published dozens of scientific papers and articles.

“Scientific discovery and entrepreneurship have been and continue to be key drivers of my career and GlycosBio embodies both,” said Monticello.  “GlycosBio has created a truly unique and revolutionary technology that can change the way biofuel, oleochemical, palm oil and petrochemical producers  not only create chemicals but also how they manage their business to increase revenue and profitability.  GlycosBio is creating better ways to make green chemicals and biofuels to help the industry more efficiently meet its long-term fuel goals.  I’m truly excited to be a part of such an innovative and talented team.”

About Glycos Biotechnologies, Inc.

Glycos Biotechnologies, Inc. (GlycosBio) is an emerging biochemical company pioneering the metabolic engineering of microbial strains to consume multiple non sugar-based, low value feedstocks for the production of sustainable chemical intermediates and advanced ethanol.  By designing differentiated microorganisms, GlycosBio’s bioconversion technology lowers production cost and provides a non food energy balance savings to the chemical and biofuel industries.  GlycosBio is privately held with established global relationships focused on product commercialization.  For more information, visit www.glycosbio.com.

(PRWEB) January 27, 2010 — Glycos Biotechnologies, Inc. (GlycosBio), an emerging biochemical company pioneering metabolic engineering and microbiology innovations that produce green chemicals, today announced the appointment of Rich Cilento as Chief Executive Officer (CEO). A Venture Advisor for DFJ Mercury and currently Executive Chairman for GlycosBio, Cilento will now be responsible for the daily operations of the company as CEO.

“As Executive Chairman, Rich has made a tremendous impact on GlycosBio’s business in a very short amount of time helping to create the foundation for the company’s future growth,” said Dan Watkins, Managing Director of DFJ Mercury. “Rich has the business, technical and leadership experience necessary to drive and execute a successful go-to-market strategy while also remaining focused on the day-to-day operations of the company. This is an exciting time for GlycosBio and I’m confident with Rich’s guidance the company will achieve their business goals.”

With more than 20 years of leadership and technical experience in the petroleum, alternative energy, information technology and now biotechnology industries, Cilento has a proven track record of creating and managing successful businesses. Prior to his role as Executive Chairman for GlycosBio, Cilento held a variety of leadership positions throughout his career including his most recent position as Founder, President and CEO of FuelQuest, Inc. (acquired by Saracen Energy), a provider of on-demand supply chain management and tax automation software for suppliers, distributors, fuel buyers and traders in the global downstream energy marketplace. Cilento has also received national business honors winning the Ernst and Young Entrepreneur of the Year Award in 2006 for Energy Technology.

“GlycosBio has developed a truly unique technology to revolutionize the way the industry produces chemicals,” said Cilento. “These new biochemicals are 100% replacement products for the chemicals that are traditionally produced using fossil fuels and other unsustainable energy sources. Furthermore, to help meet the world’s growing demand for sustainable biochemicals and biofuels, GlycosBio’s techniques and processes create biochemicals that are an economic alternative to traditional chemical and fuel processes. With some of the industry’s brightest scientists and most experienced researchers on its team, GlycosBio has already attracted the attention of prominent biofuel and chemical companies worldwide and is on the verge of announcing many exciting commercialization efforts and scientific discoveries. I look forward to leading GlycosBio and our talented and dedicated team towards a vision of producing environmentally clean biochemicals that can compete head to head with traditional fossil fuels based petrochemicals.”

About Glycos Biotechnologies, Inc. Glycos Biotechnologies, Inc. (GlycosBio) is an emerging biochemical company pioneering the metabolic engineering of microbial strains to consume multiple non sugar-based, low value feedstocks for the production of sustainable chemical intermediates and advanced ethanol. By designing differentiated microorganisms, GlycosBio’s bioconversion technology lowers production cost and provides a non food energy balance savings to the chemical and biofuel industries. GlycosBio is privately held with established global relationships focused on product commercialization. For more information, visit www.glycosbio.com.

Somewhat ironically, glycerin may be riding to its own rescue and helping out the biofuel industry at the same time.  A growing number of companies are scrambling to find uses for the abundant stuff.  One is Glycos Biotechnologies, Inc. , which is commercializing glycerin-gobbling microorganisms developed by researchers at Rice University.  The hungry bugs are at the heart of an energy-efficient bioconversion process that turns waste glycerin into fuels and other products.

Waste Glycerin into Glycerin Products

The big problem with crude glycerin waste is that the cost of disposal eats away at the profitability of biofuel operations.  GlycosBio’s approach is to integrate bioconversion into individual refinery operations.  Instead of a liability, the waste glycerin can be made into a profit center, yielding high-value chemicals (alcohols and acids) that can be used to make fabrics, insulation, and food products, as well as additional fuels.  Other researchers have been developing ways to convert glycerin into ethanol, methane, hydrogen gas, and even a non-toxic antifreeze.

Integration of Bioconversion with Biofuel Refineries

GlycosBio designed its operations to follow familiar refinery processes, which makes integration relatively easy.  The big difference is the  company’s proprietary microbe based conversion process, which requires far less heat and power.  In addition to crude glycerin, the conversion process can also work on a variety of biofuel feedstocks, perhaps including algae.

The Rice Connection

Rice University recently made news with a carbon nanotube “stew” that could bring about a significant drop in the cost of nanotube production, leading to more energy-efficient, compact and sustainable manufactured goods.  The microbial bioconversion project is another example of the university’s focus on commercializing research with environmental benefits.  Much more is coming down the pike as the Obama administration pours more federal funds into green research.

HOUSTON, TX – December 15, 2009 – Glycos Biotechnologies, Inc. (GlycosBio), an emerging biochemical company pioneering metabolic engineering and microbiology innovations that produce green chemicals, today announced the company’s inclusion in Accenture’s recent report, “Betting on Science, Disruptive Technologies in Transport Fuels”.

Issued on November 10, 2009, the study identified 12 innovations most likely to positively transform the supply and demand landscape of sustainable transport fuels and biochemicals within the next five years.  GlycosBio was among 25 companies profiled that aim to bring these unique innovations to market.
“To help meet the world’s growing demand for sustainable biochemicals and biofuels, it’s essential for the industry to understand that emerging biological techniques can be economically complementary to traditional chemical and fuel processes,” said Rich Cilento, Executive Chairman, Glycos Biotechnologies.  “Recent advancements in microbiology can enable chemical and fuel producers to leverage their existing plant assets and resources to both make money and create sustainable products.  At GlycosBio, we have developed new complementary biological pathways that allow producers to take advantage of their 1^st generation infrastructure to not only increase product diversity but also create new avenues of revenue stability while bringing an equilibrium to the supply and demand debate.”

Through the implementation of metabolic engineering, GlycosBio has developed a number of microorganisms that can convert low value by-product feedstock sources such as crude glycerin, gums, and free fatty acids into higher-value green chemicals.  GlycosBio’s technology platform provides an alternative to companies interested in biochemical and biofuel production from sugars-based fermentation techniques. By not following the typical sugars-based fermentation research, GlycosBio has created a proprietary technology that provides the industry with additional revenue and profitability opportunities from existing production assets.

To read a summary of the Accenture report, please visit http://www.accenture.com/Global/Services/By_Industry/Energy/R_and_I/Betting-on-Science.htm.

About Glycos Biotechnologies, Inc.

Glycos Biotechnologies, Inc. (GlycosBio) is an emerging biochemical company pioneering the metabolic engineering of microbial strains to consume multiple non sugar-based, low value feedstocks for the production of sustainable chemical intermediates and advanced ethanol.  By designing differentiated microorganisms, GlycosBio’s bioconversion technology lowers production cost and provides a non food energy balance savings to the chemical and biofuel industries.  GlycosBio is privately held with established global relationships focused on product commercialization.  For more information, visit www.glycosbio.com.

With a mission to find a better way to create biofuels and chemicals, GlycosBio has uniquely discovered a number of microorganisms that can biologically convert by-products including glycerol and free fatty acids into higher-value green chemicals.  By not following the typical sugars-based fermentation research, GlycosBio has created a proprietary technology that provides the industry with an alternative approach to traditional corn or sugar-based biofuel and chemical production.

In his presentation, Cilento will discuss the industry’s need to integrate microbe and fermentation technologies into their manufacturing plans.  He will provide an overview of GlycosBio’s technology and how biofuel, oleochemical, palm oil and petrochemical producers can protect themselves from the commodity risk that a single feedstock business model brings; rapidly implement a biorefinery based on their existing plant and equipment; create greater yields and increase product values.

What: “GlycosBio Business and Technology Overview”

Who: Rich Cilento, Executive Chairman, GlycosBio

Where: Alternative Energy Innovations:  Sofitel San Francisco Bay, Redwood City, CA

When: Biofuels Track: Tuesday, November 17 – 11:25am and 12:10pm

About Rich Cilento

Rich Cilento has extensive leadership and technical experience with energy, biotechnology, and information technology companies.  He received national business honors in 2006, winning the Ernst and Young Entrepreneur of the Year Award for Energy Technology.  Cilento is currently serving as Executive Chairman of DFJ Mercury portfolio company GlycosBio.  Previously, he was the Founder, President and CEO of FuelQuest, Inc. (acquired by Saracen Energy), a provider of  on-demand supply chain management and tax automation software and services for suppliers, distributors, fuel buyers and traders in Global Downstream Energy.

Cilento began his career at NASA where he was a space shuttle flight controller.  He and his flight control team had responsibility for redesigning NASA’s Mission Control Center and implementing NASA’s Software Management Plan.

Cilento holds a BS in Aeronautical and Astronomical Engineering from the University of Illinois, an MBA from the University of Houston and serves as an advisor to a number of small businesses in Texas.

About Glycos Biotechnologies, Inc.

Glycos Biotechnologies, Inc. (GlycosBio) is pioneering the metabolic engineering of microbial strains to consume multiple non sugar-based, low value feedstocks for the production of sustainable chemical intermediates and advanced ethanol.  By creating differentiated bioprocesses, GlycosBio’s bioconversion technology can lower costs, provide a non food energy balance and price stability to the chemical and biofuel industries.  GlycosBio is a Houston-based industrial biotechnology company started with technology initially developed at Rice University.  For more information, visit www.glycosbio.com.